Change search
ReferencesLink to record
Permanent link

Direct link
Pattern of antibodies to the Duffy binding-like domain of Plasmodium falciparum antigen Pf332 in Senegalese individuals
Stockholm University, Faculty of Science, The Wenner-Gren Institute , Immunology. (Kavs Berzins, Malaria Group)
Stockholm University, Faculty of Science, The Wenner-Gren Institute , Immunology.
Show others and affiliations
(English)Manuscript (preprint) (Other academic)
Keyword [en]
Pf332-DBL, antibody response, IgG3 subclass, Immunity, malaria attack
National Category
Infectious Medicine Immunology
Research subject
URN: urn:nbn:se:su:diva-60517OAI: diva2:435512
Available from: 2011-08-18 Created: 2011-08-18 Last updated: 2011-08-22Bibliographically approved
In thesis
1. Immunological characteristics of recombinant fragments of the Plasmodium falciparum blood-stage antigen Pf332
Open this publication in new window or tab >>Immunological characteristics of recombinant fragments of the Plasmodium falciparum blood-stage antigen Pf332
2011 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Effective malaria vaccine might help improve control strategies against malaria, but the complexity of interactions between the parasite and its hosts poses challenges. The asexual blood stage P. falciparum antigen Pf332 has potentials as one of the proteins in understanding the complex host-parasite interactions. The interest in Pf332 as a target for parasite neutralizing antibodies, evolved from previous studies demonstrating that Pf332-reactive antibodies inhibits parasite growth in vitro. The presence of natural P. falciparum infection also indicated that Pf332 has the ability to induce protective antibodies.

In paper I, we identified and characterized the immunogenicity of a C-terminal region of Pf332. Immunological analyses carried out with this fragment revealed that rabbit anti-C231 antibodies possess parasite in vitro inhibitory capabilities. In paper II, the functional activity of C231 specific antibodies was confirmed with human-affinity purified antibodies, where the antibodies inhibited late stage parasite development, by the presence of abnormal parasites and disintegrated red cell membranes.

Epidemiological data from malaria endemic area of Senegal (Paper III & IV), showed that antibodies were reactive with two different fragments of Pf332 (C231 and DBL). Distribution of anti-C231 antibodies in the IgG subclasses, gave similar levels of IgG2 and IgG3. The levels of anti-C231 antibodies were associated with protection from clinical malaria, but with DBL reactive antibodies IgG3 was associated with protection from clinical malaria.

We hereby conclude that antigen Pf332 contains immunogenic epitopes, and is a potential target for parasite neutralizing antibodies. The Pf332 protein should thus be considered as a candidate antigen for inclusion in a subunit P. falciparum malaria vaccine.

Place, publisher, year, edition, pages
Stockholm: The Wenner-Gren Institute, Stockholm University, 2011. 82 p.
Plasmodium falciparum, Pf332, antibodies, immunity, growth inhibition
National Category
Immunology in the medical area
Research subject
urn:nbn:se:su:diva-60540 (URN)978-91-7447-347-6 (ISBN)
Public defence
2011-09-22, Nordenskiöldsalen, Geovetenskapens hus, Svante Arrhenius väg 12, Stockholm, 10:00 (English)
At the time of the doctoral defense, the following papers were unpublished and had a status as follows: Paper 2: Submitted. Paper 4: Manuscript. Available from: 2011-08-31 Created: 2011-08-19 Last updated: 2011-08-22Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Balogun, HalimaAwah, NancyBerzins, Klavs
By organisation
Infectious MedicineImmunology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 58 hits
ReferencesLink to record
Permanent link

Direct link